RUBICON

We have developed a method to identify specific protein forms in blood, which can serve as biomarkers. This approach enables us to create a disease-specific fingerprint, with a current focus on Parkinson’s disease (PD). Our goal is to integrate this method into the existing array of common blood tests, ensuring it is user-friendly and allows for easy acquisition of results. This will facilitate early diagnosis, patient stratification, and monitoring of disease progression. Additionally, we seek to collaborate with a pharmaceutical company to assess treatment efficacy during clinical trials.

If you wish to learn more about the team or to get in touch, please reach out to Yuning Hong at Y.Hong@latrobe.edu.au.